Compounds > dipyridamole

dipyridamole and iloprost

dipyridamole has been researched along with iloprost in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A1
Darnige, L; Delahousse, B; Gruel, Y; Guilmot, JL; Lang, M; Lermusiaux, P; Leroy, J; Rupin, A1
Bugiardini, R; Ferrini, D; Galvani, M; Gridelli, C; Lenzi, S; Mari, L; Puddu, P; Tollemeto, D1
Ioannou, P; Talesnik, J1
Ghofrani, HA; Grimminger, F; Krupnik, E; Rose, F; Schermuly, RT; Schudt, C; Seeger, W; Tenor, H; Walmrath, D; Weissmann, N1
Dörffler-Melly, J; Mahler, F; Schmidli, J1
Schubert-Zsilavecz, M; Zettl, H1
Dahl, G; Qiu, F; Scemes, E; Spray, DC; Wang, J1

Reviews

1 review(s) available for dipyridamole and iloprost

ArticleYear
[Various therapy options. Medical Chemistry of platelet aggregation inhibitors].
    Pharmazie in unserer Zeit, 2009, Volume: 38, Issue:4

    Topics: Cyclooxygenase Inhibitors; Dipyridamole; Humans; Iloprost; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prostaglandin Antagonists; Purinergic P2 Receptor Antagonists; Thrombosis

2009

Other Studies

8 other study(ies) available for dipyridamole and iloprost

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24

    Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity

2012
Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis.
    Annals of vascular surgery, 1991, Volume: 5, Issue:6

    Topics: Aged; Aorta, Abdominal; Aspirin; Dipyridamole; Female; Femoral Vein; Heparin; Humans; Iliac Artery; Iliac Vein; Iloprost; Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombocytopenia; Thrombosis; Vena Cava, Inferior

1991
Myocardial ischemia induced by prostacyclin and iloprost.
    Clinical pharmacology and therapeutics, 1985, Volume: 38, Issue:1

    Topics: Adult; Aminophylline; Blood Pressure; Cardiac Output; Coronary Disease; Dipyridamole; Electrocardiography; Epoprostenol; Exercise Test; Female; Heart Rate; Humans; Iloprost; Infusions, Parenteral; Male; Middle Aged; Vascular Resistance

1985
Platelet antiaggregatory substances inhibit arachidonic acid induced coronary constriction.
    Canadian journal of physiology and pharmacology, 1986, Volume: 64, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Arachidonic Acid; Arachidonic Acids; Cardiovascular Agents; Coronary Circulation; Dipyridamole; Epoprostenol; Guinea Pigs; Heart; Hydralazine; Iloprost; In Vitro Techniques; Male; Nifedipine; Perfusion; Platelet Aggregation; Rats; Rats, Inbred Strains; Vasoconstriction

1986
Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
    American journal of respiratory and critical care medicine, 2001, Nov-01, Volume: 164, Issue:9

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aerosols; Animals; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemodynamics; Hypertension, Pulmonary; Iloprost; Naphthyridines; Pentoxifylline; Phosphodiesterase Inhibitors; Rabbits; Vasodilation; Vasodilator Agents

2001
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
    Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:1

    Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Confidence Intervals; Dipyridamole; Drug Therapy, Combination; Embolectomy; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Iloprost; Intermittent Claudication; Leg; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thrombectomy; Ticlopidine; Time Factors; Vitamin K

2003
Two non-vesicular ATP release pathways in the mouse erythrocyte membrane.
    FEBS letters, 2011, Nov-04, Volume: 585, Issue:21

    Topics: Adenosine Triphosphate; Animals; Biological Transport; Coloring Agents; Connexins; Dipyridamole; Erythrocyte Membrane; Extracellular Space; Gene Knockout Techniques; Glyburide; Humans; Iloprost; Mice; Nerve Tissue Proteins

2011